Off the Scales
[Donnellan] sets out to document the story behind Ozempic, the Novo Nordisk diabetes medication that kick-started it all in 2017 and turned the Danish company into an early winner. — Read the complete FT review
Synopsis
Through original reporting and rigorous research, Aimee Donnellan uncovers the complicated history of a medical breakthrough that is changing the world, while raising difficult questions about inequality, morality, our beauty ideals and the pursuit of thinness. Along the way, Donnellan profiles the female scientist whose contributions to the discovery of GLP-1 were overlooked and some of the earliest Ozempic users share powerful testimonies.
Off the Scales is a revelatory, gripping and urgent study of the unexpected consequences of finally getting what we’ve wanted for so long.
